166 related articles for article (PubMed ID: 9450860)
21. Factors associated with psychological distress during genetic counseling in high-risk women with breast cancer in Turkey.
Anuk D; Tuncer SB; Özkan M; Yazıcı H
Support Care Cancer; 2024 May; 32(6):359. PubMed ID: 38753118
[TBL] [Abstract][Full Text] [Related]
22. Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer.
Bjorvatn C; Eide GE; Hanestad BR; Hamang A; Havik OE
Support Care Cancer; 2009 Nov; 17(11):1371-81. PubMed ID: 19224252
[TBL] [Abstract][Full Text] [Related]
23. Psychosocial consequences of genetic counseling: a population-based follow-up study.
Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
Breast J; 2009; 15(1):61-8. PubMed ID: 19120380
[TBL] [Abstract][Full Text] [Related]
24. Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.
Baars JE; Bleiker EM; van Riel E; Rodenhuis CC; Velthuizen ME; Schlich KJ; Ausems MG
Clin Genet; 2014 Jun; 85(6):524-31. PubMed ID: 24372530
[TBL] [Abstract][Full Text] [Related]
25. The psychotherapy of genetics.
McDaniel SH
Fam Process; 2005 Mar; 44(1):25-44. PubMed ID: 15807076
[TBL] [Abstract][Full Text] [Related]
26. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
[TBL] [Abstract][Full Text] [Related]
27. Adjustment and Coping Mechanisms for Individuals with Genetic Aortic Disorders.
Connors E; Jeremy RW; Fisher A; Sharpe L; Juraskova I
Heart Lung Circ; 2015 Dec; 24(12):1193-202. PubMed ID: 26105988
[TBL] [Abstract][Full Text] [Related]
28. Men in the women's world of hereditary breast and ovarian cancer--a systematic review.
Strømsvik N; Råheim M; Oyen N; Gjengedal E
Fam Cancer; 2009; 8(3):221-9. PubMed ID: 19165626
[TBL] [Abstract][Full Text] [Related]
29. Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
Tibben A; Duivenvoorden HJ; Vegter-van der Vlis M; Niermeijer MF; Frets PG; van de Kamp JJ; Roos RA; Rooijmans HG; Verhage F
Am J Med Genet; 1993 Oct; 48(3):137-44. PubMed ID: 8291567
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
Voorwinden JS; Jaspers JP
J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
[TBL] [Abstract][Full Text] [Related]
31. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
[TBL] [Abstract][Full Text] [Related]
32. BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Høberg-Vetti H; Bjorvatn C; Fiane BE; Aas T; Woie K; Espelid H; Rusken T; Eikesdal HP; Listøl W; Haavind MT; Knappskog PM; Haukanes BI; Steen VM; Hoogerbrugge N
Eur J Hum Genet; 2016 Jun; 24(6):881-8. PubMed ID: 26350514
[TBL] [Abstract][Full Text] [Related]
33. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.
Vadaparampil ST; Ropka M; Stefanek ME
Fam Cancer; 2005; 4(2):195-206. PubMed ID: 15951974
[TBL] [Abstract][Full Text] [Related]
34. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders.
Smith CO; Lipe HP; Bird TD
Arch Neurol; 2004 Jun; 61(6):875-80. PubMed ID: 15210524
[TBL] [Abstract][Full Text] [Related]
35. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
36. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
Tibben A; Duivenvoorden HJ; Niermeijer MF; Vegter-van der Vlis M; Roos RA; Verhage F
Psychosom Med; 1994; 56(6):526-32. PubMed ID: 7871108
[TBL] [Abstract][Full Text] [Related]
37. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
[TBL] [Abstract][Full Text] [Related]
38. Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers.
Condello C; Gesuita R; Pensabene M; Spagnoletti I; Capuano I; Baldi C; Carle F; Contegiacomo A
J Genet Couns; 2007 Oct; 16(5):625-34. PubMed ID: 17701329
[TBL] [Abstract][Full Text] [Related]
39. Genetic testing for breast and ovarian cancer risk: the psychosocial issues.
Pasacreta JV; Jacobs L; Cataldo JK
Am J Nurs; 2002 Dec; 102(12):40-7; quiz 48. PubMed ID: 12473929
[No Abstract] [Full Text] [Related]
40. Psychological impact of genetic counseling for hereditary nonpolyposis colorectal cancer: the role of cancer history, gender, age, and psychological distress.
Hasenbring MI; Kreddig N; Deges G; Epplen JT; Kunstmann E; Stemmler S; Schulmann K; Willert J; Schmiegel W
Genet Test Mol Biomarkers; 2011 Apr; 15(4):219-25. PubMed ID: 21194311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
